Related Experiment Video
Updated: Mar 13, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
12.3K
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines.
Petr G Lokhov1, Elena E Balashova1
1Department of Proteomic Research and Mass Spectrometry, Institute of Biomedical Chemistry, Moscow, Russia; BioBohemia Ltd., Moscow, Russia.
Journal of Immunology Research
|October 27, 2016
Summary
Allogeneic SANTAVAC, a novel vaccine targeting tumor vasculature, shows significant efficacy in preclinical models. This approach offers a promising universal cancer vaccine strategy with minimal side effects on normal vasculature.
Area of Science:
- Oncology
- Immunology
- Vascular Biology
Background:
- Tumors alter endothelial cell surfaces, creating targets for vaccines.
- Allogeneic antigens simplify vaccine development and clinical application.
Purpose of the Study:
- To investigate the efficacy of allogeneic antigens in targeting tumor vasculature.
- To evaluate SANTAVAC (Set of All Natural Target Antigens for Vaccination Against Cancer) as a potential cancer vaccine.
Main Methods:
- In vitro studies using allogeneic SANTAVAC, a composition of tumor-endothelial cell surface antigens.
- Assessment of targeting efficacy against tumor vasculature.
Main Results:
- SANTAVAC demonstrated an efficacy of 17 (target cell killing rate) and 60 (fold decrease in target cells, indicating tumor growth arrest).
- The vaccine effectively targeted tumor vasculature without adversely affecting normal cells.
Conclusions:
- Allogeneic SANTAVAC shows potential as a universal cancer vaccine.
- Further clinical testing with adjuvants is warranted for therapeutic or prophylactic use without adverse effects on normal vasculature.
Related Concept Videos
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:26Antigens Involved in Adaptive Immunity
1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:28Diversity of Antigen Receptors
2.0K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
2.0K